PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesions' formation?

Journal of Nuclear Cardiology

Volumn 24, Issue 3, 2017, Pages 1075-1084

  Mazurek, Tomasz ^a   Kobylecka, Małgorzata ^a   Zielenkiewicz, Magdalena ^b   Kurek, Aleksandra ^c   Kochman, Janusz ^a   Filipiak, Krzysztof J ^a   Mazurek, Krzysztof ^d   Huczek, Zenon ^a   Królicki, Leszek ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c POLISH ACADEMY OF SCIENCES   (Poland)

^d JÓZEF PI SUDSKI UNIVERSITY OF PHYSICAL EDUCATION IN WARSAW   (Poland)

Author keywords

adipose tissue; atherosclerosis; FDG PET CT; stable coronary artery disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; BIOLOGICAL MARKER;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; EPICARDIAL FAT; FEMALE; HUMAN; INTRAPERITONEAL FAT; MAJOR CLINICAL STUDY; MALE; PERICORONARY ADIPOSE TISSUE; PERIVASCULAR ADIPOSE TISSUE; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; DIAGNOSTIC IMAGING; INTRA-ABDOMINAL FAT; METABOLISM; MYOCARDIAL PERFUSION IMAGING; PANNICULITIS; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

AGED; BIOMARKERS; CORONARY ARTERY DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTRA-ABDOMINAL FAT; MALE; MYOCARDIAL PERFUSION IMAGING; PANNICULITIS; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84960123634     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-015-0370-6     Document Type: Article

References (26)

1. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012;32:2045-51.
2. Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003;108:472-8.
3. Yudkin JS, Eringa E, Stehouwer CDA. “Vasocrine” signaling from perivascular fat: A mechanism linking insulin resistance to vascular disease. Lancet 2005;365:1817-20.
4. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-82.
5. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;108:2460-6.
6. Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y, Doevendans PA, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008;197:896-903.
7. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity 2008;16:887-92.
8. Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function. The Framingham heart study. Circulation 2009;119:1586-91.
9. Mazurek T. Proinflammatory capacity of adipose tissue: New insights in the pathophysiology of atherosclerosis. Kardiol Pol 2009;67(10):1119-24.
10. Mazurek T, Opolski G. Pericoronary adipose tissue: A novel therapeutic target in obesity-related coronary atherosclerosis. J Am Coll Nutr 2015;34(3):244-54.
11. Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography. Circulation 2008;117:2061-70.
12. Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, et al. Optimizing (18)F-FDG PET/CT imaging of vessel wall inflammation: The impact of (18)F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med 2014;41:369-83.
13. Mazurek T, Kiliszek M, Kobylecka M, Kochman J, Filipiak K, Królicki L, et al. Proinflammatory activity of epicardial adipose tissue may affect the occurrence of atrial fibrillation. Am J Cardiol 2014;113:1505-8.
14. Mazurek T, Kochman J, Kobylecka M, Wilimski R, Filipiak K, Królicki L, et al. Inflammatory activity of pericoronary adipose tissue may affect plaque composition in patients with acute coronary syndrome without persistent ST-segment elevation: Preliminary results. Kardiol Pol 2014;72:410-6.
15. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2013;S0140-6736:61754-7.
16. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013;159:758-69.
17. Karastergiou K, Evans I, Ogston N, Miheisi N, Nair D, Kaski JC, et al. Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler Thromb Vasc Biol 2010;30:1340-6.
18. Bigornia SJ, Farb MG, Mott MM, Hess DT, Carmine B, Fiscale A, et al. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes 2012;2:1-6.
19. Weikert C, Westphal S, Berger K, Dierkes J, Mohling M, Spranger J, et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 2008;93:2647-53.
20. Cheng VY, Dey D, Tamarappoo B, Nakazato R, Gransar H, Miranda-Peats R, et al. Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. J Am Coll Cardiol Imaging 2010;3:352-60.
21. Chen O, Sharma A, Ahmad I, Bourji N, Nestoiter K, Hua P, et al. Correlation between pericardial, mediastinal, and intrathoracic fat volumes with the presence and severity of coronary artery disease, metabolic syndrome, and cardiac risk factors. Eur Heart J Cardiovasc Imaging 2015;16:37-46.
22. Mahabadi AA, Lehmann N, Kälsch H, Robens T, Bauer M, Dykun I, et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis. Results from the Heinz Nixdorf Recall Study. J Am Coll Cardiol Imaging 2014;9:909-16.
23. Tawakol A, Singh P, Rudd JHF, Soffer J, Cai G, Vucic E, et al. Effect of treatment for 12 weeks with Rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-PET imaging. J Am Coll Cardiol 2014;63:86-8.
24. Mäki-Petäjä KM, Elkhawad M, Cheriyan J, Joshi FR, Ostor AJK, Hall FC, et al. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 2012;126:2473-80.
25. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: Results of a multi-center FDG-PET/CT feasibility study. J Am Coll Cardiol 2013;62:909-17.
26. Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, et al. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. J Am Coll Cardiol Imaging 2012;5:911-22.